CureVac N.V [CVAC] stock prices are up 37.59% to $5.60 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CVAC shares have gain 25.56% over the last week, with a monthly amount glided 64.95%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
CureVac N.V [NASDAQ: CVAC] stock has seen the most recent analyst activity on April 25, 2024, when Leerink Partners downgraded its rating to a Market Perform and also revised its price target to $4 from $12. Previously, SVB Securities started tracking the stock with Outperform rating on June 08, 2023, and set its price target to $13. On January 19, 2023, upgrade upgraded it’s rating to Buy and revised its price target to $18 on the stock. Jefferies upgraded its rating to a Buy and increased its price target to $21 on January 09, 2023. BofA Securities downgraded its rating to a Underperform and reduced its price target to $20 on January 21, 2022. JMP Securities started tracking with a Mkt Outperform rating for this stock on January 18, 2022, and assigned it a price target of $52. In a note dated October 22, 2021, Deutsche Bank initiated an Hold rating and provided a target price of $35 on this stock.
The stock price of CureVac N.V [CVAC] has been fluctuating between $2.37 and $5.00 over the past year. Currently, Wall Street analysts expect the stock to reach $29 within the next 12 months. CureVac N.V [NASDAQ: CVAC] shares were valued at $5.60 at the most recent close of the market. An investor can expect a potential return of 417.86% based on the average CVAC price forecast.
Analyzing the CVAC fundamentals
The CureVac N.V [NASDAQ:CVAC] reported sales of 574.49M for trailing twelve months, representing a drop of -93.00%. Gross Profit Margin for this corporation currently stands at 0.8% with Operating Profit Margin at 0.33%, Pretax Profit Margin comes in at 0.36%, and Net Profit Margin reading is 0.3%. To continue investigating profitability, this company’s Return on Assets is posted at 0.2, Equity is 0.29 and Total Capital is 0.24. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that CureVac N.V [NASDAQ:CVAC]’s Current Ratio is 7.65. Also, the Quick Ratio is 7.65, while the Cash Ratio stands at 6.66. Considering the valuation of this stock, the price to sales ratio is 2.19, the price to book ratio is 1.81 and price to earnings (TTM) ratio is 6.21.
Transactions by insiders
Recent insider trading involved Thaminda Ramanayake, affiliate, that happened on May 07 ’25 when 6986.0 shares were purchased. affiliate, Myriam Mendila completed a deal on Jan 07 ’25 to buy 17839.0 shares. Meanwhile, affiliate Pierre Kemula bought 51523.0 shares on Jan 07 ’25.
